Clinical • Journal • PARP Biomarker • PD(L)-1 Biomarker • IO biomarker
|
PD-L1 (Programmed death ligand 1) • PIK3CA (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) • PTEN (Phosphatase and tensin homolog) • CASP3 (Caspase 3) • EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) • CD31 (Platelet and endothelial cell adhesion molecule 1)
|
PD-L1 expression • HER-2 amplification • PIK3CA mutation • HER-2 expression • HER-2 amplification + PD-L1 expression
|
everolimus • Perjeta (pertuzumab) • Kadcyla (ado-trastuzumab emtansine) • apitolisib (GDC-0980)